印度代购提示您，丙肝，一种常见的传染病，因其具有很强的隐匿性，在感染前期无明显特征，很多感染者并不知道自己已经感染了丙肝病毒。丙肝的早期治疗非常重要，如未能及时治疗，错过治疗时机，病情就会恶化，容易发展成肝硬化、肝癌。随着国外丙肝药物的上市，使丙肝治疗进入一个新时代！丙肝的彻底根治已经成了治疗丙肝的新篇章，特别是丙肝药物吉三代。

Hepatitis C, a common infectious disease, is very insidious and has no obvious characteristics in the early stage of infection. Many infected people do not know that they have been infected with hepatitis C virus. Early treatment of hepatitis C is very important, if not timely treatment, miss the treatment opportunity, the condition will deteriorate, easy to develop into cirrhosis, liver cancer. With the listing of foreign hepatitis C drugs, the treatment of hepatitis C has entered a new era! The radical cure of hepatitis C has become a new chapter in the treatment of hepatitis C, especially the drugs of hepatitis C.

　　印度代购提示您，吉三代，全球首个也是唯一单一片剂口服治疗泛基因型的所有丙肝类型（包括1-6型）。印度“吉三代”——MyHep All是经过美国吉利德公司授权生产的仿制药，所谓仿制药与被仿制药具有相同的活性成分、剂型、给药途径和治疗作用，具有降低医疗支出、提高药品普及性和提高医疗服务水平等重要的经济和社会效益。

吉三代

　　印度代购提示您，吉三代的药效远优于吉二代和索非布韦+达卡他韦，治愈高达99%以上，副作用极小，治疗时间较短，仅需12周治疗丙肝即可痊愈。吉三代在III期临床试验中其有效性和安全性得到了充分的验证。

　　印度代购提示您，在三个全球性的III期临床试验中，1000多名未出现肝硬化，或出现代偿期肝硬化的丙肝患者完成了整个疗程，其中有高达98%的患者在12周后未能检测出丙肝病毒。如有需要，请咨询印度代购海外医疗医学顾问：4006-130-650或扫码添加下方微信，我们将竭诚为您服务！

In three global Phase III clinical trials, more than 1,000 patients with hepatitis C who did not develop cirrhosis, or who developed compensatory cirrhosis, completed the full course of treatment, with up to 98% undetectable hepatitis C virus after 12 weeks. If you need, please consult India purchasing overseas medical consultants: 4006-130-650 or scan code to add below wechat, we will serve you wholeheartedly!